SpyGlass Pharma, Inc.SGP
Price (close)
$27.65
Market cap
$924.8M
P/E
—
Revenue (FY)
—
Net income
-$39.9M
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
—
Debt / equity
—
What SpyGlass Pharma, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net income | — | -$29.2M | -$39.9M |
| Free cash flow | — | -$24.0M | -$33.5M |
More on SGP.
- SpyGlass Pharma, Inc. summary
- SpyGlass Pharma, Inc. financial statements
- SpyGlass Pharma, Inc. key metrics
- SpyGlass Pharma, Inc. health scores and style box
- SpyGlass Pharma, Inc. earnings
- SpyGlass Pharma, Inc. dividends
- SpyGlass Pharma, Inc. valuation
- SpyGlass Pharma, Inc. ownership and insiders
- SpyGlass Pharma, Inc. peers
Figures from SpyGlass Pharma, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.